GMGoran Marjanovic

Goran Marjanovic

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Goran Marjanovic has a total of 98 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Weight Loss Measurements Under the Microscope: How Type and Baseline Definition Shape Clinical Response After Metabolic-Bariatric Surgery — A 2-Year Follow-up Analysis of 17,568 Patients

    by Mira Fink, Geoffroy Andrieux, Stephan Herrmann, Ning Wei, Luisa Schäfer, Claudia Lässle, Andreas Tsouris, Jodok Fink, Goran Marjanovic, Stefan Fichtner-Feigl, et al.

    Background: In the era of modern metabolic-bariatric surgery, increasing attention is being paid to the assessment of clinical response after surgery. With the growing availability of multimodal obesity treatment, including preoperative pharmacological and lifestyle interventions, identification and optimization of factors associated with a suboptimal clinical response after metabolic-bariatric surgery (MBS) have become increasingly important. When considering weight loss specifically, two methodological factors substantially influence the interpretation of postoperative response: the metric used to quantify weight loss (percent total weight loss [%TWL] versus percent excess weight loss [%EWL]) and the baseline from which the weight-loss trajectory is calculated. Objective: To illustrate how different weight-loss metrics and baseline definitions influence the interpretation of postoperative response and the apparent association between preoperative characteristics and suboptimal clinical response after MBS. Methods: We analyzed 17,568 patients from the StuDoQ|MBE registry who underwent primary MBS and had complete 2-year postoperative follow-up data. Postoperative suboptimal clinical response was assessed using the 2024 IFSO reporting threshold of <20% TWL. Because the registry did not contain sufficiently standardized longitudinal information on improvement of obesity-related complications, the clinical component of the IFSO definition could not be incorporated. The historical threshold of <50% EWL was additionally analyzed as a surrogate criterion to facilitate comparison with previous literature. Multivariable generalized linear mixed-effects models were used to evaluate the associations of preoperative BMI and preoperative weight loss with these weight-loss-based outcomes. Analyses distinguished between cumulative weight loss, calculated from the earliest documented weight before initiation of preoperative weight reduction, and postsurgical weight loss, calculated from weight at the time of surgery to follow-up. Partial-effects plots and heatmaps were used to visualize the modeled associations. Results: The proportion of patients classified according to weight-loss-based criteria for suboptimal clinical response varied substantially according to the metric used, with more patients meeting the historical <50% EWL criterion than the IFSO-consistent <20% TWL threshold. Higher preoperative BMI was associated with a greater probability of meeting the historical <50% EWL criterion, whereas the association was reversed when suboptimal response was defined using <20% TWL. The definition of the baseline weight also substantially influenced the interpretation of preoperative weight loss. Greater preoperative weight loss was associated with a lower probability of weight-loss-based suboptimal clinical response when assessed cumulatively from the beginning of the preoperative treatment trajectory, whereas greater preoperative weight loss was associated with a higher probability of meeting the postsurgical suboptimal weight-loss criteria when weight at the day of surgery was used as the baseline. Conclusion: The choice of weight-loss metric and baseline definition substantially influences the classification of postoperative weight-loss response and the apparent association between preoperative characteristics and surgical outcomes. %EWL and %TWL are not interchangeable measures and can produce opposing interpretations of the association between baseline BMI and postoperative response. Consistent with the 2024 IFSO consensus, weight-loss assessment after MBS should use a baseline established before initiation of preoperative weight reduction where appropriate, particularly when evaluating the overall treatment trajectory. %TWL provides a more readily comparable metric for standardized reporting, whereas %EWL may remain useful for comparison with historical literature. Because clinical response after MBS is multidimensional, weight-loss thresholds should not be interpreted as synonymous with clinical treatment failure.

  • Adipositastherapie im Wandel: Chirurgie und Medikamente – Ergänzung statt Konkurrenz

    by Goran Marjanovic, Gabriel Seifert

    Adipositas ist eine der größten gesundheitspolitischen und chirurgischen Herausforderungen unserer Zeit. Rund ein Viertel der deutschen Erwachsenen ist adipös, in spezialisierten Zentren liegt der durchschnittliche Body-Mass-Index (BMI) der behandelten Patient*innen bei etwa 49 kg/m² [1]. Chirurg*innen sehen sich täglich mit Patient*innen konfrontiert, deren Krankheitslast enorm ist und für die Monotherapien – sei es Chirurgie oder Pharmakotherapie – häufig nicht ausreichen. Klassische Lebensstilprogramme bleiben in dieser Patientengruppe fast immer erfolglos. Während die metabolische Chirurgie nach wie vor die effektivste Einzeltherapie darstellt, gewinnen hochpotente Medikamente zunehmend an Relevanz. Der Fokus muss sich daher von der Frage „Chirurgie oder Medikamente?“ hin zu einem integrativen Konzept „Chirurgie und Medikamente“ verschieben – ein Ansatz, der interdisziplinäres Denken und neue, passende Versorgungsstrukturen erfordert. Article published online: 30 March 2026 © 2026. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

  • Open Access

    Long-Term Outcomes of Pouch Resizing with Ring Augmentation for Dumping Syndrome and Weight Trajectory after Roux-en-Y Gastric Bypass: A Single-Center Experience

    by Stephan Herrmann, Henrietta Pross, Gabriel Seifert, Claudia Lässle, Ning Wei, Stefan Fichtner-Feigl, Goran Marjanovic, Dalibor Bockelmann

    Introduction: Dumping syndrome (DS) and recurrent weight gain are among the most relevant long-term challenges following Roux-en-Y gastric bypass (RYGB). Several treatment strategies have been proposed, including pouch resizing with ring augmentation (PRRA). This study presents long-term outcomes of PRRA, with a focus on weight trajectory and the management of DS symptoms. Methods: A retrospective analysis of all PRRA procedures performed at a tertiary referral center between January 2008 and September 2023. Clinical data were obtained from electronic health records and patient questionnaires. Results: Sixty-two patients (90.3 % female, mean age at time of RYGB 40.2 ± 9.5 years, mean BMI 47.4 ± 7.9 kg/m 2 ) underwent PRRA at a mean interval of 56.3 ± 34.6 months after RYGB. DS was the leading indication (74.2 %), followed by recurrent weight gain (24.2 %) and primary suboptimal clinical response (1.6%). Following PRRA, 62.8 % of patients (n = 45) reported long-term improvement in DS-related symptoms, and 79 % (n = 57) achieved renewed weight loss. Long-term weight stabilization was observed, with only modest recurrent weight gain (+2.1± 5.4 kg/m 2 from post-PRRA nadir weight) after a mean follow-up of 48.6± 40.0 months. Ring removal was required in 25.8 % of patients, predominantly due to dysphagia and regurgitation. Conclusions: PRRA is an effective revisional option for managing DS symptoms after RYGB and contributes to sustained weight stability in patients with recurrent weight gain. However, ring-related adverse effects may necessitate removal in a subset of patients.

  • Open Access

    Ring Augmentation and Pouch Resizing for the Treatment of Dumping Syndrome After Roux-en-Y Gastric Bypass: A Prospective Single-Center Trial

    by Jodok Matthias Fink, Mareike Luehn, Maximilian Meyer-Steenbuck, Gabriel Seifert, Sephan Herrmann, Stefan Fichtner-Feigl, Jochen Seufert, Goran Marjanovic, Katharina Laubner

    Background: Early dumping syndrome (DS) and postbariatric surgery hypoglycemia (PBH) are common side effects after Roux-en-Y gastric bypass (RYGB) and may substantially impact patients’ quality of life. Established management options provide limited response in many patients. This trial tested the effect of pouch resizing and silicone ring implantation (trial intervention) in patients with dumping symptoms after RYGB. Methods: The trial intervention was assessed in a prospective single-arm trial including 16 patients. The primary endpoint was the change in Sigstad score 12 months after surgery. Secondary endpoints included Arts dumping score, insulin secretion, and glucose uptake assessed by a mixed meal tolerance test (MMTT), weight loss, quality of life, and safety evaluated by gastroscopy and contrast swallow. Results: The trial intervention led to a significant improvement in Sigstad (preOP: 20.4 (95% CI 17.8–23.1); 12 months: 10.4 (6.7–14.1); P = 0.0002) and Arts dumping score (preOP: 20.3 (16.7–23.9); 12 months: 10 (6.5–13.5); P = 0.0001). Glucose uptake and insulin secretion during MMTT remained largely unchanged (AUC glucose: 21,526 (19,654–23,398) mg/dl*min vs. 12 months 22,294 (20,511–24077) mg/dl*min), P = 0.21; AUC insulin: (preOP 62897 (33,531–92,263) pmol/l*min vs. 12 months 68,974 (40,691–97257) pmol/l*min, P = 0.19). Following the trial intervention, mean weight loss was 5.1% (1.4–8.9%). No ring migration or misplacement occurred during follow-up. Conclusions: Pouch resizing and silicone ring implantation led to a clinically relevant improvement in symptoms associated with DS and PBH. This was not related to an apparent impact on glycemic regulation. Graphical


  • Open Access

    Artificial Intelligence-Based Comparison of Duodenojejunostomy and Sleeve Gastrectomy on Pancreatic Morphology in Zucker Diabetic Fatty Rats

    by Luisa Schaefer, Ambrus Malyi, Gabriel Seifert, Mira Fink, Stephan Herrmann, Uwe Pohlen, Bernhard Huegel, Peter Bronsert, Stefan Fichtner-Feigl, Goran Marjanovic, et al.

    Introduction Obesity and type 2 diabetes mellitus (T2D) are interrelated metabolic disorders with increasing global incidence. Bariatric surgeries such as sleeve gastrectomy (SG) and Roux-en Y gastric bypass (RYGB) improve glycemic control, yet their effects on pancreatic morphology and function remain incompletely understood. This study compared the effects of SG, duodenojejunostomy (DJOS), and their combination (DJOS + SG) on glucose regulation and pancreatic histomorphology in Zucker diabetic fatty (ZDF) rats using artificial intelligence (AI)-assisted tissue analysis. Methods Forty-five male ZDF rats were randomized into three surgical groups (SG, DJOS, DJOS + SG). Oral glucose tolerance tests (OGTT) and insulin levels were assessed at 1, 3 and 6 months post-surgery. Pancreatic tissue was analyzed histologically and immunohistochemically for beta cell mass, PCNA and PDX-1 expression. QuPath software enabled AI-based quantification of acinar, adipose, and fibrotic tissue. Results DJOS and DJOS + SG improved glucose tolerance and increased fasting insulin compared to SG. Both bypass groups demonstrated greater beta cell mass and clustering, elevated 6 PCNA and PDX-1 expression, and more acinar tissue. SG was associated with reduced beta cell presence and increased pancreatic adiposity. Conclusions Malabsorptive (DJOS) or combination bariatric procedures (DJOS + SG) significantly enhance glycemic control in the rat model. Concomitantly, beta cell apoptosis is reduced, leading to increased beta cell numbers and clustering, along with enhanced beta cell proliferation and differentiation. Acinar glandular tissue is increased with a reduction in pancreatic adiposity following bypass surgery.

  • Laparoskopische Sleeve-Gastrektomie

    by Goran Marjanovic, Jodok Fink

  • Standardoperationen in der Adipositaschirurgie

    by Goran Marjanovic, Gabriel Seifert, Claudia Läßle, Jodok Fink

    Jeder Vierte in Deutschland ist adipös. Folglich ist die Nachfrage für adipositaschirurgische Eingriffe bundesweit sehr hoch. Immer mehr Kliniken bieten Adipositasoperationen an und lassen sich als Adipositaszentren zertifizieren. Die Eingriffe sind im Vergleich zu anderen viszeralchirurgischen Operationsverfahren extrem standardisiert und langfristig erfolgreich, was eine tiefergehende Auseinandersetzung mit den genauen Techniken, den Indikationen und den Ergebnissen nahelegt. Article published online: 26 September 2022 © 2022. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

  • Open Access

    Long-Term Diabetes Improvement After Duodenal Exclusion in Zucker Diabetic Fatty Rats Is Associated with Prevention of Strain-Specific Pancreatic Remodeling and Increased Beta Cell Proliferation

    by Gabriel Seifert, Ambrus Malyi, Peter Bronsert, Sven Plohmann, Rebeccca Kesselring, Stefan Fichtner-Feigl, Goran Marjanovic, Jodok Matthias Fink, Claudia Laessle

    Background: Response to metabolic surgery is heterogeneous and the metabolic states that underpin weight loss and metabolic improvement are still unclear. In this study, we investigate parameters of post-bariatric fasting glucoregulation and leverage artificial intelligence-assisted whole-slide image analyses to characterize associated immunohistologic features of the pancreas. Materials and Methods: We performed either loop duodeno-jejunostomy (DJOS) with exclusion of 1/3 of total intestinal length, loop duodeno-ileostomy with exclusion of 2/3 of total intestinal length (DiOS), or a sham operation on 8-week-old male obese ZDF rats. Six months post-operative, we measured blood metabolites and hormones. Subsequently, pancreatic and intestinal tissue was removed, formalin fixed, and paraffin embedded. Immunohistologic (IHC) analyses included proliferating cell nuclear antigen (PCNA) to visualize the proliferation fraction and pancreatic and duodenal homeobox 1 (PDX 1) as a measure of pancreatic cell differentiation. For IHC quantification, all slides were digitalized and analyzed using QuPath. All analyzed slides were reviewed by two independent pathologists for correctness. Results: DJOS and DiOS were associated with preserved fasting insulin production compared to sham. Histopathologic evaluation showed significantly higher numbers of beta cells and specifically of clustered cell organization in DJOS and DiOS compared to sham. Cell proliferation (PCNA) was significantly elevated in DJOS and DiOS compared to sham. Conclusion: In this interventional model of bariatric surgery in severe genetic diabetes, we demonstrate post-operative histologic and immunohistologic features of the pancreas associated with improved fasting glucose homeostasis. Graphical


  • The New Interest of Bariatric Surgeons in the Old Ligamentum Teres Hepatis

    by Alexander Runkel, Oliver Scheffel, Goran Marjanovic, Norbert Runkel

    The search for an operation that effectively prevents and treats intrathoracic gastric migration (ITGM) after bariatric surgery has revived a long-forgotten technique: ligamentum teres cardiopexy (LTC) by which a vascularized flap of the teres ligament is wrapped around the distal esophagus. The systematic search of publications in the English language revealed 4 studies (total number of patients 53) in the non-bariatric literature with an unsatisfactory resolution of GERD. There were 5 reports from the bariatric literature with small patient numbers (total 64) and a short follow-up (6–36 months). There were no objective signs of gastric remigration in 93% of investigated patients. Acknowledging the limitations of these preliminary reports, bariatric surgeons are encouraged to further investigate the potentials of LTC in their patients.